Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Comparing fixed-rate versus time-programmed decreasing IV PCA after surgery

Official title: Prospective Randomized Controlled Study of Individualized PCA Model Based on Multi-dimensional Strategies (Fixed-rate Basal Infusion Mode and Time-programmed Decremental Background Infusion Mode)

Run by Beijing Tiantan Hospital · NCT07375121 · Data updated 2026-11-12

This trial will try two different IV patient-controlled analgesia infusion methods to see which reduces opioid use and improves pain control for adults after elective mixed surgery.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment450 (estimated)
SponsorBeijing Tiantan Hospital
Academic / other
Locations1 site (Beijing)
StatusRecruiting
StartedDecember 30, 2025
Main results expectedOctober 30, 2026
Study endsDecember 30, 2026
Registry record updatedApril 6, 2026
Trial IDNCT07375121 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–65 with ASA physical status I–III who are scheduled for elective mixed surgeries (for example thoracoscopic, laparoscopic, hysteroscopic, laparotomy, thoracotomy, open spinal surgery, or craniotomy) are ideal candidates.

Probably not a fit

Patients with chronic pain syndromes, psychiatric disorders, severe cardiac/cerebrovascular disease, significant renal or hepatic dysfunction, or allergies to PCA medications are unlikely to benefit or be eligible for this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults having elective mixed surgery will receive intravenous patient-controlled analgesia programmed either as a fixed-rate basal infusion or as a time-programmed decremental background infusion. The study will compare total opioid consumption, postoperative pain scores, and the incidence of opioid-related adverse events between the two infusion modes. Patients aged 18–65 with ASA physical status I–III who meet eligibility criteria will be enrolled at Beijing Tiantan Hospital and assigned to one of the two PCA strategies. Results are intended to support more individualized and time-adaptive postoperative pain management.

Why it matters

Potential benefit: If successful, the optimized PCA mode could lower opioid doses, improve postoperative pain relief, and reduce opioid-related side effects.

How similar studies have gone: Related PCA optimization approaches have been tested in smaller studies with some promise in reducing opioid use and side effects, but evidence is mixed and not yet widely adopted.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* aged between 18 to 65 years;
* American Society of Anesthesiologists physical status Ⅰ - Ⅲ;
* Patients scheduled for elective mixed surgery were enrolled. Mixed surgeries included thoracoscopic surgery, laparoscopic surgery, hysteroscopy surgery, laparotomy, thoracotomy, open spinal surgery, craniotomy, and so on.

Exclusion Criteria:

* Chronic pain syndromes;
* Psychiatric disorders;
* Severe cardiovascular or cerebrovascular disease, renal or hepatic functional dysfunction, or allergic to PCA medications.

Where it's running

  • Beijing Tiantan Hospital, Beijing, Beijing 100070
    Beijing, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.